What is the standard protocol for administering Antivenom Serum (ASV) in Normal Saline (NS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration of Antivenom Serum (ASV) in Normal Saline

The standard protocol for administering Antivenom Serum (ASV) is to dilute it in normal saline (NS) and administer as an intravenous infusion, with careful monitoring for infusion reactions.

Preparation of ASV

  • ASV should be reconstituted according to manufacturer's instructions if in lyophilized (powder) form
  • Dilute the required number of vials in 500 ml of normal saline for adults 1
  • For pediatric patients, use a smaller volume of normal saline that is appropriate for the child's size
  • Use sterile technique during preparation 1
  • Ensure proper labeling of the infusion with drug name, concentration, and date 1

Administration Protocol

Initial Administration

  1. Establish secure intravenous access, preferably with a large-bore cannula
  2. Start infusion at a slow rate for the first 10-15 minutes (approximately 15-20 drops/minute)
  3. Monitor patient closely during this initial period as most severe reactions occur within the first 10 minutes 1
  4. If no reaction occurs, gradually increase the rate to complete the infusion over 1 hour

Monitoring During Administration

  • Continuous monitoring of vital signs (blood pressure, pulse, respiratory rate, oxygen saturation)
  • Observe for signs of hypersensitivity reactions:
    • Mild: Pruritus, flushing, urticaria, chest tightness
    • Moderate: Transient cough, shortness of breath, tachycardia, hypotension
    • Severe: Loss of consciousness, severe hypotension, airway angioedema 1

Management of Infusion Reactions

If a reaction occurs:

  1. STOP the infusion immediately
  2. Maintain IV access with normal saline at keep-vein-open (KVO) rate
  3. Notify physician and perform physical assessment
  4. Administer appropriate medications based on severity:

For Mild Reactions:

  • Antihistamine (Diphenhydramine 25-50 mg IV/PO)
  • Consider slowing infusion rate when restarted

For Moderate to Severe Reactions:

  • Administer epinephrine 0.3-0.5 mg (0.3-0.5 ml of 1:1000) IM into the mid-outer thigh for adults
  • For children: 0.01 mg/kg (maximum 0.3 mg) 2
  • Position patient supine with legs elevated if hypotensive
  • Administer IV fluids (NS bolus 1000-2000 ml) for hypotension
  • Consider corticosteroids (Hydrocortisone 100-500 mg IV)
  • For respiratory symptoms, consider albuterol nebulizer 1, 2

Special Considerations

  • Keep emergency medications and equipment readily available during ASV administration
  • For high-dose ASV administration (as may be required in severe envenomation), continue to use the same dilution protocol but monitor more frequently 3
  • The total number of vials required depends on the severity of envenomation and clinical response
  • In case of 76 vials (as mentioned in the question), divide into multiple infusions of 500 ml NS each to avoid fluid overload
  • Recurrence of symptoms may occur after initial improvement, requiring additional ASV administration 4

Common Pitfalls to Avoid

  1. Delayed administration: Early administration of ASV is critical for preventing irreversible venom effects 5
  2. Inadequate dilution: Always dilute ASV properly in NS to reduce risk of reactions
  3. Rapid infusion: Administering too quickly increases risk of severe reactions
  4. Inadequate monitoring: Close observation is essential during the entire infusion
  5. Premature discontinuation: Complete the full course even if symptoms improve
  6. Failure to prepare for reactions: Always have epinephrine and resuscitation equipment ready

By following this protocol, ASV can be administered safely and effectively to manage snake envenomation while minimizing the risk of adverse reactions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Krait bite requiring high dose antivenom: a case report.

The Southeast Asian journal of tropical medicine and public health, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.